Ann M. Veneman - Jun 10, 2022 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role
Director
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Ann M. Veneman
Stock symbol
ICVX
Transactions as of
Jun 10, 2022
Transactions value $
$0
Form type
4
Date filed
6/14/2022, 05:07 PM
Previous filing
Aug 2, 2021
Next filing
Jun 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Award $0 +5.54K +65.21% $0.00 14K Jun 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +22.3K $0.00 22.3K Jun 10, 2022 Common Stock 22.3K $6.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") which will vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date.
F2 1/12th of the total number of shares of common stock subject to the option vest monthly following June 10, 2022, the vesting commencement date, provided if the next occurring annual meeting of the Issuer's stockholders occurs prior to the full vesting of the option, any remaining options will vest on the date of such annual meeting, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.